Product Name	beta-Actin (Loading Control)
Chinese Name	β-肌动蛋白/β-Actin（内参）抗体
Alias	Beta Actin; beta-Actin; ACTB; Actin cytoplasmic 1; Actin, beta; Beta actin; beta cytoskeletal actin; A X actin like protein; ACTB; Actin cytoplasmic 1; alpha sarcomeric Actin; Actx; Beta cytoskeletal actin; Melanoma X actin; PS1TP5BP1; ACTB_HUMAN.  β actin; βactin;
literatures	Specific References  (1140)     |     SL0061R has been referenced in 1140 publications. [IF=3.192]   WB ;  Pig.   PubMed:32888967 [IF=4.087]   WB ;  Rat.   PubMed:33300653 [IF=20.042] Xiang-Qian Gao. et al. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N 6 -methyladenosine methylation of Parp10 mRNA. Nat Cell Biol. 2020 Oct;22(11):1319-1331  WB ;  Mouse.   PubMed:33020597 [IF=19.227] Xin Zhou. et al. ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression. BRAIN BEHAV IMMUN. 2023 Mar;109:331  WB ;  Mouse.   PubMed:36791893 [IF=18.027] Nguyen Thi Nguyen. et al. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy. ACS NANO. 2022;XXXX(XXX):XXX-XXX  WB ;  Mouse.   PubMed:36579941 [IF=16.744] Rui Liu. et al. Engineered stem cell biomimetic liposomes carrying levamisole for macrophage immunity reconstruction in leukemia therapy. CHEM ENG J. 2022 Nov;447:137582  WB ;  Rat.   PubMed:10.1016/j.cej.2022.137582 [IF=15.84] Xiaolie He. et al. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells. 2021 Feb 25  WB ;  Mouse.   PubMed:10.1002/advs.202003535 [IF=15.304] Yao Lei. et al. Phytochemical natural killer cells reprogram tumor microenvironment for potent immunotherapy of solid tumors. BIOMATERIALS. 2022 Jun;:121635  WB ;  Mouse.   PubMed:10.1016/j.biomaterials.2022.121635 [IF=14.976] Qinyu Ma. et al. Small extracellular vesicles deliver osteolytic effectors and mediate cancer‐induced osteolysis in bone metastatic niche. J Extracell Vesicles. 2021 Feb;10(4):e12068  WB ;  Mouse.   PubMed:33659051 [IF=14.903] Shuai Xiong. et al. Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window. ACTA PHARM SIN B. 2023 May;:  WB ;  Mouse.   PubMed:10.1016/j.apsb.2023.05.012 [IF=14.26] Mi Bai. et al. LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO MOL MED. 2023 Jan 11  WB ;  Mouse.   PubMed:36629048 [IF=14.026] Congcong Chen. et al. Radix Paeoniae Alba attenuates Radix Bupleuri-induced hepatotoxicity by modulating gut microbiota to alleviate the inhibition of saikosaponins on glutathione synthetase. J PHARM ANAL. 2023 Apr;:  WB ;  Rat.   PubMed:10.1016/j.jpha.2023.04.016 [IF=13.273] Danmin Lin. et al. Brain-targeted gene delivery of ZnO quantum dots nanoplatform for the treatment of Parkinson disease. Chem Eng J. 2022 Feb;429:132210  WB ;  Human.   PubMed:10.1016/j.cej.2021.132210 [IF=13.273] Long Zhao. et al. Juglone-loaded metal-organic frameworks for H2O2 self-modulating enhancing chemodynamic therapy against prostate cancer. Chem Eng J. 2022 Feb;430:133057  WB ;  Human.   PubMed:10.1016/j.cej.2021.133057 [IF=13.273] Xinkun Shen. et al. Improvement of aqueous stability and anti-osteoporosis properties of Zn-MOF coatings on titanium implants by hydrophobic raloxifene. Chem Eng J. 2021 Oct;:133094  WB ;  Mouse.   PubMed:10.1016/j.cej.2021.133094 [IF=12.336] Baikai Ma. et al. Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf. 2021 Apr;20:70  WB ;  Human.   PubMed:10.1016/j.jtos.2020.12.007 [IF=11.556] Wen-juan Jiang. et al. Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy. Theranostics. 2022; 12(1): 324–339  WB ;  Mouse,Human.   PubMed:34987648 [IF=11.48] Lan, Feng, et al. "Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3." Journal of Allergy and Clinical Immunology 132.6 (2013): 1314-1321.  WB ;  Human.   PubMed:23910692 [IF=11.33] Leclercq, Sophie, et al. "Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior." Nature Communications 8 (2017): 15062.  WB ;  Mouse.   PubMed:28375200 [IF=11.161] Zhipeng Jiang. et al. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway. J Exp Clin Canc Res. 2021 Dec;40(1):1-15  WB ;  Human.   PubMed:34253241 [IF=10.787] Xiaozhen Dai. et al. Nrf2 transcriptional upregulation of IDH2 to tune mitochondrial dynamics and rescue angiogenic function of diabetic EPCs. REDOX BIOL. 2022 Oct;56:102449  WB ;  Mouse.   PubMed:36063728 [IF=10.787] Yi Zhao. et al. Ferroptosis is critical for phthalates driving the blood-testis barrier dysfunction via targeting transferrin receptor. REDOX BIOL. 2023 Feb;59:102584  WB ;  Mouse.   PubMed:36580806 [IF=10.753] Fangwei Yang. et al. Diethyl phosphate disrupts hypothalamus-pituitary-adrenal axis endocrine hormones via nuclear receptors GR and Nur77: Integration of evidences from in vivo, in vitro and in silico approaches. SCI TOTAL ENVIRON. 2022 Oct;844:157015  WB ;  Rat, Human.   PubMed:35777568 [IF=10.753] Ya-Nan Gao. et al. Aflatoxin M1 and ochratoxin A induce a competitive endogenous RNA regulatory network of intestinal immunosuppression by whole-transcriptome analysis. SCI TOTAL ENVIRON. 2022 Sep;:158777  WB ;  Human.   PubMed:36115400 [IF=10.75] Hu Yifang. et al. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development. INT J BIOL SCI. 2023 Apr;19(7):2034-2052  WB ;  Human.   PubMed:37151881 [IF=10.383] Zhen Xu. et al. Green Biosynthesis of Silver Nanoparticles Using Aqueous Extracts of Ageratum Conyzoides and Their Anti-Inflammatory Effects. ACS APPL MATER INTER. 2023;XXXX(XXX):XXX-XXX  WB ;  Mouse,Human.   PubMed:36881383 [IF=10.19] Xianqiang Li. et al. Menthol nanoliposomes enhanced anti-tumor immunotherapy by increasing lymph node homing of dendritic cell vaccines. CLIN IMMUNOL. 2022 Sep;:109119  WB ;  Mouse.   PubMed:36109005 [IF=10.171] Ping Pang. et al. The circular RNA circHelz enhances cardiac fibrosis by facilitating the nuclear translocation of YAP1. TRANSL RES. 2023 Feb;:  WB ;  Mouse.   PubMed:36775059 [IF=9.933] Xingyi Xu. et al. A Honeycomb-Like Bismuth/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple-Negative Breast Cancer Targeted Therapy. 2021 Jul 23  WB ;  Human.   PubMed:34297897 [IF=9.918] Jie Hao. et al. Multifunctional miR181a nanoparticles promote highly efficient radiotherapy for rectal cancer. MATER TODAY ADV. 2022 Dec;16:100317  WB ;  Mouse.   PubMed:10.1016/j.mtadv.2022.100317
Product Type	Internal reference anti
Research Area	Tumour  Cell biology  Signal transduction  Cytoskeleton
Immunogen Species	Rabbit
Clonality	Polyclonal
React Species	Human, Mouse, Rat, Hamster, 3 (predicted: Chicken, Dog, Pig, Rabbit, Sheep, Bee, Fish, Guinea Pig, Cat, 2)
Applications	WB=1:5000-50000 ELISA=1:5000-20000 IHC-P=1:100-500 Flow-Cyt=1μg/Test ICC=1:100 （Paraffin sections need antigen repair） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
Theoretical molecular weight	42kDa
Cellular localization	cytoplasmic
Form	Liquid
Concentration	1mg/ml
immunogen	Synthetic MAP peptide derived from human beta-Actin: 1-200/375
Lsotype	IgG
Purification	affinity purified by Protein A
Buffer Solution	0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Storage	Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Attention	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed	PubMed
Product Detail	Loading Control This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, and integrity. This actin is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins. [provided by RefSeq, Jul 2008]. Function: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. Subunit: Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to 4 others. Identified in a mRNP granule complex, at least composed of ACTB, ACTN4, DHX9, ERG, HNRNPA1, HNRNPA2B1, HNRNPAB, HNRNPD, HNRNPL, HNRNPR, HNRNPU, HSPA1, HSPA8, IGF2BP1, ILF2, ILF3, NCBP1, NCL, PABPC1, PABPC4, PABPN1, RPLP0, RPS3, RPS3A, RPS4X, RPS8, RPS9, SYNCRIP, TROVE2, YBX1 and untranslated mRNAs. Component of the BAF complex, which includes at least actin (ACTB), ARID1A, ARID1B/BAF250, SMARCA2, SMARCA4/BRG1, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57 SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more of SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C. In muscle cells, the BAF complex also contains DPF3. Found in a complex with XPO6, Ran, ACTB and PFN1. Component of the MLL5-L complex, at least composed of MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT. Interacts with XPO6 and EMD. Interacts with ERBB2. Subcellular Location: Cytoplasm. cytoskeleton. Tissue Specificity: Ubiquitously expressed in all eukaryotic cells. Post-translational modifications: ISGylated. Oxidation of Met-44 by MICALs (MICAL1, MICAL2 or MICAL3) to form methionine sulfoxide promotes actin filament depolymerization. Methionine sulfoxide is produced stereospecifically, but it is not known whether the (S)-S-oxide or the (R)-S-oxide is produced. DISEASE: Defects in ACTA1 are the cause of nemaline myopathy type 3 (NEM3) [MIM:161800]. A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-or rod-like structures in muscle fibers on histologic examination. The phenotype at histological level is variable. Some patients present areas devoid of oxidative activity containg (cores) within myofibers. Core lesions are unstructured and poorly circumscribed. Defects in ACTA1 are a cause of myopathy congenital with excess of thin myofilaments (MPCETM) [MIM:161800]. A congenital muscular disorder characterized at histological level by areas of sarcoplasm devoid of normal myofibrils and mitochondria, and replaced with dense masses of thin filaments. Central cores, rods, ragged red fibers, and necrosis are absent. Similarity: Belongs to the actin family. SWISS: P60709 Gene ID: 60 Database links: Entrez Gene: 396526 Chicken Entrez Gene: 60 Human Entrez Gene: 11461 Mouse Entrez Gene: 100009272 Rabbit Entrez Gene: 81822 Rat Omim: 102630 Human SwissProt: P60706 Chicken SwissProt: P60712 Cow SwissProt: P60708 Horse SwissProt: P60709 Human SwissProt: P60710 Mouse SwissProt: P29751 Rabbit SwissProt: P60711 Rat SwissProt: P60713 Sheep Unigene: 520640 Human Unigene: 708120 Human Unigene: 727576 Human Unigene: 328431 Mouse Unigene: 391967 Mouse Unigene: 94978 Rat Internal reference anti β-Actin是横纹肌肌纤维中的一种主要蛋白质成分，也是肌肉细丝及Cytoskeleton微丝的主要成分。具有收缩功能，分布广泛，具有高度保守性，在细胞中的表达相对稳定，因此常被用作校正系统的内参。β-Actin分子量为42 kDa， 此抗体主要用于标记平滑肌及其来源的Tumour。 我公司开发的β-Actin抗体已被国内外广大科研工作者使用，被称为质量信得过产品.
Product Picture	Sample: A549 Cell (Human) Lysate at 30 ug Primary: Lane1: Anti-beta-Actin (SL0061R) at 1/500 dilution Lane2: Anti-beta-Actin (SL0061R) at 1/1000 dilution Lane3: Anti-beta-Actin (SL0061R) at 1/2000 dilution Lane4: Anti-beta-Actin (SL0061R) at 1/4000 dilution Lane5: Anti-beta-Actin (SL0061R) at 1/5000 dilution Lane6: Anti-beta-Actin (SL0061R) at 1/8000 dilution Lane7: Anti-beta-Actin (SL0061R) at 1/10000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Lane1: 293T Cell Lysate at 25 ug Lane2: A549 Cell Lysate at 25 ug Lane3: A431 Cell Lysate at 25 ug Primary: Anti- beta-Actin (SL0061R) at 1/1000 and 1/5000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42kD Observed band size: 42 kD Sample: Lung lysate at 30ug; Primary: Anti-beta-actin (SL0061R) at 1:1000 dilution Secondary: HRP conjugated Goat-Anti-Rabbit IgG(bse-0295G) at 1:3000 dilution Predicted band size : 42kD Observed band size : 42kD Sample: SH-SY5Y (Human) Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/2000~1/20000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Thymus (Mouse) Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/1000~1/20000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: HL60 (Human) Cell Lysate at 40 ug HUVEC (Human) Cell Lysate at 40 ug Spinal cord (Rat) Lysate at 40 ug Rectum (Rat) Lysate at 40 ug Placenta (Rat) Lysate at 40 ug Lymph node (Rat) Lysate at 40 ug Lung (Rat) Lysate at 40 ug Spleen (Rat) Lysate at 40 ug JAR (Human) Cell Lysate at 40 ug 293T (Human) Cell Lysate at 40 ug Jurkat (Human) Cell Lysate at 40 ug TM4 (Human) Cell Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: A549 (Human) Cell Lysate at 40 ug Raw264.7 (Mouse) Cell Lysate at 40 ug SH-SY5Y (Human) Cell Lysate at 40 ug MKN45 (Human) Cell Lysate at 40 ug CHO (Hamster) Cell Lysate at 40 ug Panc-1 (Human) Cell Lysate at 40 ug 4T1 (Mouse) Cell Lysate at 40 ug ASPC-1 (Human) Cell Lysate at 40 ug H9C2 (Rat) Cell Lysate at 40 ug Brl-3a (Rat) Cell Lysate at 40 ug TT (Human) Cell Lysate at 40 ug TEV-1 (Human) Cell Lysate at 40 ug EC9706 (Human) Cell Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Thymus (Mouse) Lysate at 40 ug Urinary bladder (Mouse) Lysate at 40 ug Uterus (Mouse) Cell Lysate at 40 ug Aorta (Mouse) Lysate at 40 ug olfactory bulb (Mouse) Lysate at 40 ug Cerebellum (Mouse) Lysate at 40 ug Adrenal gland (Mouse) Lysate at 40 ug Ovary (Mouse) Lysate at 40 ug Ear (Mouse) Lysate at 40 ug U2os (Human) Cell Lysate at 40 ug ASPC-1 (Human) Cell Lysate at 40 ug Vas deferens (Mouse) Lysate at 40 ug trachea (Mouse) Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Embryo Cerebrum (Mouse) Lysate at 40 ug Du145 (Human) Lysate at 40 ug SW480 (Human) Cell Lysate at 40 ug U87MG (Human) Lysate at 40 ug U251 (Human) Lysate at 40 ug A673 (Human) Lysate at 40 ug Lovo (Human) Lysate at 40 ug 293FT (Human) Lysate at 40 ug JEG-3 (Human) Lysate at 40 ug RSC96 (Rat) Cell Lysate at 40 ug MCF-7 (Human) Cell Lysate at 40 ug HepG2 (Human) Lysate at 40 ug A431 (Human) Lysate at 40 ug Primary: Anti-beta-Actin (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Lung (Mouse) Lysate at 40 ug Cerebrum (Mouse) Lysate at 40 ug Primary: Anti-beta-Actin (Loading Control) (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Sample: Lung (Mouse) Lysate at 40 ug Uterus (Mouse) Lysate at 40 ug Small intestine (Mouse) Lysate at 40 ug Primary: Anti- beta-Actin (SL0061R) at 1/2000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 42 kD Observed band size: 42 kD Tissue/cell: human cervical carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min; Incubation: Anti-Beta-actin Polyclonal Antibody, Unconjugated(SL0061R) 1:1500, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining Tissue/cell: Hela cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum, C-0005) at 37°C for 20 min; Antibody incubation with (beta-Actin) polyclonal Antibody, Unconjugated (SL0061R) 1:100, 90 minutes at 37°C; followed by a conjugated Goat Anti-Rabbit IgG-FITC antibody at 37°C for 90 minutes, DAPI (blue, C02-04002) was used to stain the cell nuclei. MCF7 cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum, C-0005) at 37°C for 20 min; Antibody incubation with (beta-Actin) polyclonal Antibody, Unconjugated (SL0061R) 1:100, 90 minutes at 37°C; followed by a conjugated Goat Anti-Rabbit IgG antibody at 37°C for 90 minutes, DAPI (blue, C02-04002) was used to stain the cell nuclei. MCF7 cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum, C-0005) at 37°C for 20 min; Antibody incubation with (beta-Actin) polyclonal Antibody, Unconjugated (SL0061R) 1:100, 90 minutes at 37°C; followed by a conjugated Goat Anti-Rabbit IgG antibody at 37°C for 90 minutes, DAPI (blue, C02-04002) was used to stain the cell nuclei. Blank control: NIH/3T3. Primary Antibody (green line): Rabbit Anti-beta-Actin (Loading Control) antibody (SL0061R) Dilution: 1μg /10^6 cells; Isotype Control Antibody (orange line): Rabbit IgG . Secondary Antibody : Goat anti-rabbit IgG-AF4 Cartpieces 9 9Delete 5 5Delete S SDelete R RDelete + +Delete 8 8Delete Delete Delete 1 1Delete 1 1Delete $ $Delete 0 0Delete 1 1Delete $ $Delete 0 0Delete 0 0Delete 1 1Delete B BDelete B BDelete Delete i iDelete i iDelete Delete 1 1Delete Delete 1 1Delete 1 1Delete 0 0Delete Delete 2 2Delete 1 1Delete 0 0Delete 0 0Delete 0 0Delete 0 0Delete 0 0Delete 0 0Delete 1 1Delete 1 1Delete Delete - -Delete - -Delete 0 0Delete Delete t tDelete 0 0Delete 0 0Delete 0 0Delete f fDelete Delete Delete Delete Delete Delete Delete Delete Delete Delete Delete Delete Delete Delete Delete 1 1Delete $ $Delete Delete 0 0Delete Delete Delete Delete R RDelete 5 5Delete A ADelete Totalgoods,subtotals:￥Checkout Bought notes(bought amounts latest0) No one bought this product Total 0 records, divided into1 pages First Prev Next Last User Comment(Total0User Comment Num) No comment Total 0 records, divided into1 pages First Prev Next Last Username： Anonymous user E-mail： Rank： Content： Verification code： Call us +86 571 56623320 Email [email protected] Address Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China Join Us with Support Share About Us Contact Us Privacy Policy Shipping Policy Payment Policy Quality Guarantee Return & Refund policy Download Product list Leave a message Please select message type Products inquiry (price, lead time, order, etc.) Products inquiry (technical inquiry) Suggestions on website optimization Other suggestions * To protect against spam, please pass the CAPTCHA test below. +86 571 56623320 [email protected] +86 18668110335 Scan Wechat Qrcode